Applications of antisense oligonucleotides in designing a therapy for spinal muscular atrophy

Loren Louise Price

    Research output: ThesisDoctoral Thesis

    173 Downloads (Pure)

    Abstract

    Spinal muscular atrophy (SMA) is a devastating neurodegenerative disease for which there is currently no cure. SMA is caused by an insufficiency of the survival motor neuron protein that leads to loss of motor neurons, muscle denervation and wastage. The study presented in this thesis focused on designing and evaluating splice-switching antisense oligonucleotides that increase survival motor neuron protein levels as a potential therapy for SMA. Furthermore, this study investigates the mechanisms of action of different applications of antisense oligonucleotides, as well as drawing attention to deleterious off­ target effects of particular antisense oligonucleotide chemistries.
    Original languageEnglish
    QualificationDoctor of Philosophy
    Awarding Institution
    • The University of Western Australia
    Supervisors/Advisors
    • Wilton, Steve, Supervisor
    • Fletcher, Susan, Supervisor
    • Palmer, Norman, Supervisor
    • Thompson, Philip, Supervisor
    Award date24 Oct 2017
    DOIs
    Publication statusUnpublished - 2017

    Fingerprint

    Dive into the research topics of 'Applications of antisense oligonucleotides in designing a therapy for spinal muscular atrophy'. Together they form a unique fingerprint.

    Cite this